Clinical Trial Update: Comparison of the Efficacy and Safety of Mirogabalin and Duloxetine in Chemotherapy-induced Peripheral Neuropathy in a Randomized Controlled Trial: a Quality of Life Study in Cancer Survivors [NA]

View source ↗

Summary

This document outlines a planned randomized trial comparing Mirogabalin to Duloxetine for chemotherapy-induced peripheral neuropathy in cancer survivors, focusi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Peripheral Neuropathy

Drugs mentioned

• Duloxetine (DULOXETINE)
• Mirogabalin (mirogabalin besilate)

Snippet

Sponsor: Pusan National University Yangsan Hospital | Conditions: CIPN, CIPN - Chemotherapy-Induced Peripheral Neuropathy | NA | Status: NOT_YET_RECRUITING